Lucky No. 7

Frazier tailors seventh biotech fund to fit in LPs' $250-$400M sweet spot

In raising its seventh fund, Frazier Healthcare took the advice of LPs who suggested bigger is not always better. The fund closed last week at $377 million, overshooting its $300 million target but coming in well below the $600 million fund Frazier closed in 2007.

LPs are decreasing their venture

Read the full 491 word article

How to gain access

Continue reading with a
two-week free trial.